News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ADAMS THOMAS PHD
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.72, valued at
$111.6k
|
|
| 06/19/2020 |
4
| ADAMS THOMAS PHD (Executive Chairman) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 173,145 options
@ $2.6, valued at
$450.2k
|
|
| 05/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
| 07/25/2019 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 970 options
@ $3.24, valued at
$3.1k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2018 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 27,785 shares
@ $0
Exercised 100,023 options
@ $0.5, valued at
$50k
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2018 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 54,322 options
@ $0.3, valued at
$16.3k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/21/2016 |
3
| ADAMS THOMAS PHD (Director) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 06/29/2016 |
4/A
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 62,500 options
@ $3.67, valued at
$229.4k
|
|
| 06/27/2016 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 62,500 options
@ $3.67, valued at
$229.4k
|
|
| 01/06/2016 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 16,000 options
@ $5.18, valued at
$82.9k
|
|
| 07/28/2015 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 29,000 options
@ $7.91, valued at
$229.4k
|
|
| 03/19/2015 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 16,000 options
@ $7.18, valued at
$114.9k
|
|
| 12/09/2014 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 62,000 options
@ $2.98, valued at
$184.8k
|
|
| 06/12/2014 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 21,000 options
@ $4.24, valued at
$89k
|
|
| 02/26/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/16/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2012 |
4
| ADAMS THOMAS PHD (CTO & Corporate V.P.) has filed a Form 4 on IRIS INTERNATIONAL INC|
Txns:
| Unknown transaction of 231,665 shares
@ $19.5, valued at
$4.5M
Unknown transaction of 7,090 shares
@ $19.5, valued at
$138.3k
Exercised 15,555 shares
@ $17.82, valued at
$277.2k
Exercised 29,167 shares
@ $11.65, valued at
$339.8k
Exercised 17,453 shares
@ $9.99, valued at
$174.4k
Exercised 19,848 shares
@ $11.97, valued at
$237.6k
Paid exercise price by delivering 58,257 shares
@ $19.5, valued at
$1.1M
Sold 23,766 shares
@ $19.5, valued at
$463.4k
Exercised 15,555 options to buy
@ $17.82, valued at
$277.2k
Exercised 29,167 options to buy
@ $11.65, valued at
$339.8k
Exercised 17,453 options to buy
@ $9.99, valued at
$174.4k
|
|
| 10/02/2012 |
4
| ADAMS THOMAS PHD (CTO & Corporate V.P.) has filed a Form 4 on IRIS INTERNATIONAL INC|
Txns:
| Exercised 293 restricted stock units
@ $0 |
|
| 08/09/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/03/2012 |
4
| ADAMS THOMAS PHD (CTO & Corporate V.P.) has filed a Form 4 on IRIS INTERNATIONAL INC|
Txns:
| Paid exercise price by delivering 108 shares
@ $11.3, valued at
$1.2k
Paid exercise price by delivering 72 shares
@ $11.3, valued at
$813.6
Exercised 292 restricted stock units
@ $0 |
|
| 04/03/2012 |
4
| ADAMS THOMAS PHD (CTO & Corporate V.P.) has filed a Form 4 on IRIS INTERNATIONAL INC|
Txns:
| Paid exercise price by delivering 108 shares
@ $13.51, valued at
$1.5k
Paid exercise price by delivering 160 shares
@ $13.51, valued at
$2.2k
Exercised 292 restricted stock units
@ $0 |
|
| 03/28/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|